2020 № 4 Evaluation of the prospects for developing a vaccine against coronavirus infection by means of patent analysis
A cross-country comparison of the patent activity of various countries in the field of the development of antiviral drugs, in particular vaccines against coronavirus infection, was carried out. The companies with the most voluminous and authoritative portfolios of patent documents have been identified. Particular attention was paid to the practices used by pharmaceutical companies in the face of intense competition. The importance of protecting the rights to technical solutions with patents issued outside the Russian Federation has been shown.